Monday, 27 December 2010

Ceftazidime Labatec




Ceftazidime Labatec may be available in the countries listed below.


Ingredient matches for Ceftazidime Labatec



Ceftazidime

Ceftazidime is reported as an ingredient of Ceftazidime Labatec in the following countries:


  • Switzerland

International Drug Name Search

Wednesday, 22 December 2010

Rivanolum




Rivanolum may be available in the countries listed below.


Ingredient matches for Rivanolum



Ethacridine

Ethacridine lactate (a derivative of Ethacridine) is reported as an ingredient of Rivanolum in the following countries:


  • Poland

International Drug Name Search

Monday, 20 December 2010

Terminax




Terminax may be available in the countries listed below.


Ingredient matches for Terminax



Terbinafine

Terbinafine is reported as an ingredient of Terminax in the following countries:


  • Guatemala

International Drug Name Search

Cytapen




Cytapen may be available in the countries listed below.


Ingredient matches for Cytapen



Phenoxymethylpenicillin

Phenoxymethylpenicillin is reported as an ingredient of Cytapen in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 9 December 2010

Carboplatino Ferrer Farma




Carboplatino Ferrer Farma may be available in the countries listed below.


Ingredient matches for Carboplatino Ferrer Farma



Carboplatin

Carboplatin is reported as an ingredient of Carboplatino Ferrer Farma in the following countries:


  • Spain

International Drug Name Search

Sunday, 5 December 2010

Gengraf




In the US, Gengraf (cyclosporine systemic) is a member of the drug class calcineurin inhibitors and is used to treat Idiopathic Thrombocytopenic Purpura, Organ Transplant - Rejection Prophylaxis, Organ Transplant - Rejection Reversal, Psoriasis and Rheumatoid Arthritis.

US matches:

  • Gengraf

  • Gengraf Solution

  • Gengraf Capsules

Ingredient matches for Gengraf



Ciclosporin

Ciclosporin is reported as an ingredient of Gengraf in the following countries:


  • Chile

  • China

  • Hong Kong

  • Malaysia

  • Singapore

  • Thailand

  • Turkey

  • United States

International Drug Name Search

Saturday, 4 December 2010

Menamig




Menamig may be available in the countries listed below.


Ingredient matches for Menamig



Frovatriptan

Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Menamig in the following countries:


  • Switzerland

International Drug Name Search

Friday, 26 November 2010

Pethilorfan




Pethilorfan may be available in the countries listed below.


Ingredient matches for Pethilorfan



Levallorphan

Levallorphan tartrate (a derivative of Levallorphan) is reported as an ingredient of Pethilorfan in the following countries:


  • Japan

Pethidine

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Pethilorfan in the following countries:


  • Japan

International Drug Name Search

Tuesday, 23 November 2010

Glicerolo Afom




Glicerolo Afom may be available in the countries listed below.


Ingredient matches for Glicerolo Afom



Glycerol

Glycerol is reported as an ingredient of Glicerolo Afom in the following countries:


  • Italy

International Drug Name Search

Quixidar




Quixidar may be available in the countries listed below.


Ingredient matches for Quixidar



Fondaparinux

Fondaparinux Sodium is reported as an ingredient of Quixidar in the following countries:


  • Slovakia

International Drug Name Search

Sunday, 21 November 2010

Irinogen




Irinogen may be available in the countries listed below.


Ingredient matches for Irinogen



Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Irinogen in the following countries:


  • Argentina

  • Ecuador

International Drug Name Search

UDCA Ferring




UDCA Ferring may be available in the countries listed below.


Ingredient matches for UDCA Ferring



Ursodeoxycholic Acid

Ursodeoxycholic Acid is reported as an ingredient of UDCA Ferring in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 17 November 2010

Doxi-OM




Doxi-OM may be available in the countries listed below.


Ingredient matches for Doxi-OM



Calcium Dobesilate

Calcium Dobesilate is reported as an ingredient of Doxi-OM in the following countries:


  • Portugal

International Drug Name Search

Friday, 12 November 2010

Captopril T.S.




Captopril T.S. may be available in the countries listed below.


Ingredient matches for Captopril T.S.



Captopril

Captopril is reported as an ingredient of Captopril T.S. in the following countries:


  • Italy

International Drug Name Search

MCR-Uno




MCR-Uno may be available in the countries listed below.


Ingredient matches for MCR-Uno



Morphine

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of MCR-Uno in the following countries:


  • Israel

International Drug Name Search

Sunday, 24 October 2010

Desyrel




In the US, Desyrel (trazodone systemic) is a member of the drug class phenylpiperazine antidepressants and is used to treat Anxiety, Depression, Fibromyalgia, Insomnia, Reflex Sympathetic Dystrophy Syndrome and Sedation.

US matches:

  • Desyrel

  • Desyrel Dividose

Ingredient matches for Desyrel



Trazodone

Trazodone hydrochloride (a derivative of Trazodone) is reported as an ingredient of Desyrel in the following countries:


  • Canada

  • Japan

  • Turkey

International Drug Name Search

Tuesday, 12 October 2010

Inflocine




Inflocine may be available in the countries listed below.


Ingredient matches for Inflocine



Niflumic Acid

Niflumic Acid is reported as an ingredient of Inflocine in the following countries:


  • Tunisia

International Drug Name Search

Sunday, 10 October 2010

Fluoxétine Qualimed




Fluoxétine Qualimed may be available in the countries listed below.


Ingredient matches for Fluoxétine Qualimed



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxétine Qualimed in the following countries:


  • France

International Drug Name Search

Wednesday, 6 October 2010

Bayopet




Bayopet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bayopet



Cypermethrin

Cypermethrin is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Fenthion

Fenthion is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Praziquantel

Praziquantel is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Propoxur

Propoxur is reported as an ingredient of Bayopet in the following countries:


  • South Africa

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Bayopet in the following countries:


  • South Africa

International Drug Name Search

Elequine




Elequine may be available in the countries listed below.


Ingredient matches for Elequine



Levofloxacin

Levofloxacin hemihydrate (a derivative of Levofloxacin) is reported as an ingredient of Elequine in the following countries:


  • Antigua & Barbuda

  • Aruba

  • Bahamas

  • Barbados

  • Bermuda

  • Cayman Islands

  • Costa Rica

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Grenada

  • Guatemala

  • Guyana

  • Honduras

  • Jamaica

  • Mexico

  • Netherlands Antilles

  • Nicaragua

  • Panama

  • Saint Lucia

  • Saint Vincent & The Grenadines

  • Suriname

  • Trinidad & Tobago

International Drug Name Search

Acido Pamidronico




Acido Pamidronico may be available in the countries listed below.


Ingredient matches for Acido Pamidronico



Pamidronic Acid

Pamidronic Acid is reported as an ingredient of Acido Pamidronico in the following countries:


  • Peru

International Drug Name Search

Monday, 4 October 2010

Gluben




Gluben may be available in the countries listed below.


Ingredient matches for Gluben



Glibenclamide

Glibenclamide is reported as an ingredient of Gluben in the following countries:


  • Israel

International Drug Name Search

Xbac




Xbac may be available in the countries listed below.


Ingredient matches for Xbac



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Xbac in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 1 October 2010

Kliovance




Kliovance may be available in the countries listed below.


UK matches:

  • Kliovance
  • Kliovance (SPC)

Ingredient matches for Kliovance



Estradiol

Estradiol is reported as an ingredient of Kliovance in the following countries:


  • New Zealand

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Kliovance in the following countries:


  • Australia

  • United Kingdom

Norethisterone

Norethisterone 17Ăź-acetate (a derivative of Norethisterone) is reported as an ingredient of Kliovance in the following countries:


  • Australia

  • New Zealand

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 28 September 2010

Gaseoflat




Gaseoflat may be available in the countries listed below.


Ingredient matches for Gaseoflat



Simeticone

Simeticone is reported as an ingredient of Gaseoflat in the following countries:


  • Peru

International Drug Name Search

Saturday, 25 September 2010

Irizz




Irizz may be available in the countries listed below.


Ingredient matches for Irizz



Alprazolam

Alprazolam is reported as an ingredient of Irizz in the following countries:


  • Mexico

International Drug Name Search

Wednesday, 22 September 2010

Scandonest




Scandonest may be available in the countries listed below.


Ingredient matches for Scandonest



Epinephrine

Epinephrine is reported as an ingredient of Scandonest in the following countries:


  • Bulgaria

Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Scandonest in the following countries:


  • Switzerland

Mepivacaine

Mepivacaine hydrochloride (a derivative of Mepivacaine) is reported as an ingredient of Scandonest in the following countries:


  • Australia

  • Bulgaria

  • Denmark

  • Estonia

  • Italy

  • Japan

  • Latvia

  • Malta

  • Netherlands

  • Norway

  • Poland

  • Slovenia

  • Switzerland

International Drug Name Search

Sunday, 19 September 2010

Farmacaina




Farmacaina may be available in the countries listed below.


Ingredient matches for Farmacaina



Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Farmacaina in the following countries:


  • Venezuela

International Drug Name Search

Fluconazol Teva




Fluconazol-Teva may be available in the countries listed below.


Ingredient matches for Fluconazol-Teva



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol-Teva in the following countries:


  • Spain

  • Switzerland

International Drug Name Search

Tuesday, 14 September 2010

Diuremid




Diuremid may be available in the countries listed below.


Ingredient matches for Diuremid



Torasemide

Torasemide is reported as an ingredient of Diuremid in the following countries:


  • Italy

International Drug Name Search

Monday, 13 September 2010

Avandia




In the US, Avandia (rosiglitazone systemic) is a member of the drug class thiazolidinediones and is used to treat Diabetes - Type 2 and Nonalcoholic Fatty Liver Disease.

US matches:

  • Avandia

UK matches:

  • Avandia 4mg & 8mg film-coated Tablets (SPC)

Ingredient matches for Avandia



Rosiglitazone

Rosiglitazone is reported as an ingredient of Avandia in the following countries:


  • Bulgaria

  • Portugal

Rosiglitazone maleate (a derivative of Rosiglitazone) is reported as an ingredient of Avandia in the following countries:


  • Antigua & Barbuda

  • Argentina

  • Aruba

  • Australia

  • Austria

  • Bahamas

  • Bahrain

  • Barbados

  • Belgium

  • Bermuda

  • Bosnia & Herzegowina

  • Brazil

  • Canada

  • Cayman Islands

  • Chile

  • China

  • Colombia

  • Costa Rica

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Finland

  • France

  • Germany

  • Greece

  • Grenada

  • Guatemala

  • Guyana

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Ireland

  • Israel

  • Italy

  • Jamaica

  • Luxembourg

  • Malaysia

  • Mexico

  • Myanmar

  • Netherlands

  • Netherlands Antilles

  • New Zealand

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Romania

  • Russian Federation

  • Saint Lucia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sri Lanka

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Trinidad & Tobago

  • Turkey

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ifex


Ifex is a brand name of ifosfamide, approved by the FDA in the following formulation(s):


IFEX (ifosfamide - injectable; injection)



  • Manufacturer: BAXTER HLTHCARE

    Approval date: December 30, 1988

    Strength(s): 1GM/VIAL [AP], 3GM/VIAL [AP]

Has a generic version of Ifex been approved?


No. There is currently no therapeutically equivalent version of Ifex available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ifex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Ifex.

See also...

  • Ifex Solution Consumer Information (Wolters Kluwer)
  • Ifex Consumer Information (Cerner Multum)
  • Ifex Advanced Consumer Information (Micromedex)
  • Ifosfamide Solution Consumer Information (Wolters Kluwer)
  • Ifosfamide Consumer Information (Cerner Multum)
  • Ifosfamide Intravenous Advanced Consumer Information (Micromedex)
  • Ifex/Mesnex Kit AHFS DI Monographs (ASHP)
  • Ifosfamide AHFS DI Monographs (ASHP)

Saturday, 4 September 2010

Rifadin


Generic Name: rifampin (Oral route)

rif-AM-pin

Commonly used brand name(s)

In the U.S.


  • Rifadin

  • Rimactane

Available Dosage Forms:


  • Capsule

  • Tablet

  • Syrup

Therapeutic Class: Antitubercular


Chemical Class: Rifamycin


Uses For Rifadin


Rifampin is used together with other medicines to treat tuberculosis (TB) in many different parts of the body. It is also used by patients who have a meningitis bacteria in their nose or throat to prevent the spread of the bacteria to other patients. Rifampin belongs to the class of medicines called antibiotics and works to kill or prevent the growth of bacteria. However, it will not work for colds, flu, or other virus infections.


This medicine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, rifampin is used in certain patients with the following medical conditions:


  • Atypical mycobacterial infections, such as Mycobacterium avium complex (MAC).

  • Leprosy (Hansen's disease).

  • Prevention of Haemophilus influenzae infection.

  • Treatment of serious staphylococcal (bacterial) infections.

Before Using Rifadin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of rifampin in children.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of rifampin in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Atazanavir

  • Boceprevir

  • Darunavir

  • Fosamprenavir

  • Lopinavir

  • Lurasidone

  • Nifedipine

  • Praziquantel

  • Ranolazine

  • Rilpivirine

  • Saquinavir

  • Telaprevir

  • Tipranavir

  • Voriconazole

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abiraterone

  • Amiodarone

  • Amprenavir

  • Atovaquone

  • Cabazitaxel

  • Crizotinib

  • Cyclosporine

  • Dabigatran Etexilate

  • Dasatinib

  • Delavirdine

  • Dronedarone

  • Efavirenz

  • Erlotinib

  • Ethionamide

  • Etravirine

  • Everolimus

  • Imatinib

  • Indinavir

  • Irinotecan

  • Isoniazid

  • Itraconazole

  • Ixabepilone

  • Lapatinib

  • Linagliptin

  • Lorcainide

  • Maraviroc

  • Mycophenolate Mofetil

  • Nelfinavir

  • Nevirapine

  • Nilotinib

  • Pazopanib

  • Posaconazole

  • Pyrazinamide

  • Quetiapine

  • Quinine

  • Ritonavir

  • Rivaroxaban

  • Roflumilast

  • Romidepsin

  • Sirolimus

  • Sunitinib

  • Tacrolimus

  • Telithromycin

  • Temsirolimus

  • Ticagrelor

  • Tolvaptan

  • Vandetanib

  • Vemurafenib

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acetyldigoxin

  • Aliskiren

  • Anisindione

  • Aprepitant

  • Atorvastatin

  • Betamethasone

  • Bexarotene

  • Bosentan

  • Buspirone

  • Carbamazepine

  • Carvedilol

  • Caspofungin

  • Chloramphenicol

  • Chlorpropamide

  • Citalopram

  • Clarithromycin

  • Clofibrate

  • Clozapine

  • Cortisone

  • Deferasirox

  • Desogestrel

  • Dexamethasone

  • Dicumarol

  • Dienogest

  • Digoxin

  • Diltiazem

  • Disopyramide

  • Doxycycline

  • Drospirenone

  • Eltrombopag

  • Enalaprilat

  • Enalapril Maleate

  • Estradiol Cypionate

  • Estradiol Valerate

  • Ethinyl Estradiol

  • Ethynodiol Diacetate

  • Etonogestrel

  • Fentanyl

  • Fesoterodine

  • Fluconazole

  • Fludrocortisone

  • Fosaprepitant

  • Fosphenytoin

  • Gefitinib

  • Gliclazide

  • Glyburide

  • Haloperidol

  • Isradipine

  • Ketoconazole

  • Lamotrigine

  • Leflunomide

  • Levomethadyl

  • Levonorgestrel

  • Levothyroxine

  • Linezolid

  • Losartan

  • Medroxyprogesterone Acetate

  • Mefloquine

  • Mestranol

  • Metformin

  • Methadone

  • Methylprednisolone

  • Metoprolol

  • Morphine

  • Morphine Sulfate Liposome

  • Moxifloxacin

  • Nisoldipine

  • Norelgestromin

  • Norethindrone

  • Norgestimate

  • Norgestrel

  • Oxycodone

  • Phenprocoumon

  • Phenytoin

  • Pioglitazone

  • Pirmenol

  • Pitavastatin

  • Prednisolone

  • Prednisone

  • Propafenone

  • Raltegravir

  • Repaglinide

  • Rofecoxib

  • Rosiglitazone

  • Ruxolitinib

  • Sertraline

  • Simvastatin

  • Tadalafil

  • Tamoxifen

  • Theophylline

  • Tocainide

  • Triazolam

  • Trimetrexate

  • Valproic Acid

  • Warfarin

  • Zaleplon

  • Zidovudine

  • Zolpidem

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Alcohol abuse, or history of—Use with caution. May cause side effects to become worse.

  • Diabetes, history of or

  • Liver disease or

  • Porphyria (an enzyme problem)—Use with caution. May make these conditions worse.

Proper Use of rifampin

This section provides information on the proper use of a number of products that contain rifampin. It may not be specific to Rifadin. Please read with care.


Take this medicine exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. To do so may increase the chance for side effects.


To help clear up your infection completely, it is very important that you keep using this medicine for the full time of treatment, even if you begin to feel better after a few weeks. If you have TB, you might have to take rifampin every day for several months. It is important that you not miss any doses.


Take the capsule on an empty stomach, 1 hour before or 2 hours after a meal, with a full of glass water. If you take this medicine on a regular schedule it will help prevent side effects.


If you or your child use antacids (e.g., Maalox®, Mylanta®), do not take rifampin with the antacids. Take the capsule 1 hour before you use the antacid.


For patients unable to swallow the capsule:


  • A special liquid form of the medicine can be prepared by a pharmacist.

  • Shake the bottle well before each dose.

  • Measure the liquid with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For the treatment of meningitis bacteria in the nose or throat:
      • Adults—600 milligrams (mg) two times per day for 2 days.

      • Children and infants 1 month of age and older—Dose is based on body weight and must be determined by your doctor. The dose is 10 mg per kilogram (kg) of body weight every 12 hours for 2 days.

      • Infants younger than 1 month of age—Dose is based on body weight and must be determined by your doctor. The dose is 5 mg per kg of body weight every 12 hours for 2 days.


    • For the treatment of tuberculosis:
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is 10 milligrams (mg) per kilogram (kg) of body weight once a day. Your doctor may increase your dose as needed. However, the dose is usually not more than 600 mg per day.

      • Children—Dose is based on body weight and must be determined by your doctor. The dose is 10 to 20 mg per kg of body weight once a day. Your doctor may increase your dose as needed. However, the dose is usually not more than 600 mg per day.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


The specially prepared liquid form may be kept at room temperature or in a refrigerator for 4 weeks. Do not use the liquid after the expiration date on the label.


Precautions While Using Rifadin


It is very important that your doctor check the progress of you or your child at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it. Blood tests may be needed to check for unwanted effects.


You should not use this medicine if you or your child are also receiving atazanavir, darunavir, fosamprenavir, ritonavir, saquinavir, tipranavir, Aptivus®, Fortovase®, Invirase®, Lexiva®, Norvir®, Prezista®, or Reyataz®. These medicines are used to treat human immunodeficiency virus (HIV) infections.


Liver problems may occur with this medicine. The risk for liver problems is increased if you drink alcoholic beverages on a regular basis. You should limit the amount of alcoholic beverages you drink while you are receiving this medicine. If you have any concerns about this, talk to your doctor.


Stop using this medicine and check with your doctor right away if you or your child have pain or tenderness in the upper stomach; pale stools; dark urine; loss of appetite; nausea; unusual tiredness or weakness; or yellow eyes or skin. These could be symptoms of a serious liver problem.


Rifampin will cause urine, stool, saliva, sputum, sweat, and tears to turn a reddish-orange to reddish-brown color. This is to be expected while you are using this medicine, and everything will return to normal once you stop using it. This effect may cause soft contact lenses to become permanently discolored, so it is best not to wear soft contact lenses while you are using this medicine. If you or your child have any questions about this, check with your doctor.


Birth control pills may not work properly while you are taking this medicine. To keep from getting pregnant, use another form of birth control together with your birth control pills. Other forms include condoms, diaphragms, or contraceptive foams or jellies.


Before you have any medical tests, tell the doctor in charge that you or your child are taking this medicine. The results of some tests may be affected by this medicine.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Rifadin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Abdominal or stomach pain

  • agitation

  • back pain

  • bleeding gums

  • blood in the urine or stools

  • bruising

  • confusion

  • cough or hoarseness

  • coughing or vomiting blood

  • dark urine

  • darkening of the skin

  • decreased frequency or amount of urine

  • difficulty with swallowing

  • dizziness

  • fainting

  • fast heartbeat

  • fever with or without chills

  • general feeling of tiredness or weakness

  • headache

  • hives

  • hostility

  • increased blood pressure

  • increased thirst

  • irritability

  • lethargy

  • light-colored stools

  • loss of appetite

  • lower back or side pain

  • mental depression

  • nausea and vomiting

  • painful or difficult urination

  • persistent bleeding or oozing from puncture sites, mouth, or nose

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • shortness of breath

  • skin itching, rash, or redness

  • sores, ulcers, or white spots on the lips or in the mouth

  • swelling of the face, ankles, fingers, hands, or lower legs

  • tightness in the chest

  • tiredness

  • troubled breathing

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • weight gain

  • wheezing

  • yellow eyes or skin

Incidence not known
  • Blistering, peeling, or loosening of the skin

  • bloating

  • bone pain

  • chest pain

  • chills

  • cold, clammy skin

  • diarrhea, watery and severe, which may also be bloody

  • difficulty with speaking

  • double vision

  • fast heartbeat

  • fast, weak pulse

  • inability to move the arms, legs, or facial muscles

  • inability to speak

  • joint or muscle pain

  • lightheadedness

  • pale skin

  • pinpoint red spots on the skin

  • red skin lesions, often with a purple center

  • red, irritated eyes

  • redness, soreness, or itching skin

  • slow speech

  • sores, welting, or blisters

  • sweating

  • swollen glands

  • unpleasant breath odor

  • unusual weight loss

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Blurred vision

  • convulsions (seizures)

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • fast, pounding, or irregular heartbeat or pulse

  • full feeling in the upper abdomen or stomach

  • itching

  • low blood pressure or slow pulse

  • nausea or vomiting

  • pain in the upper abdomen or stomach

  • reddish-orange to reddish-brown color of the urine, stool, saliva, sputum, sweat, and tears

  • swelling around the eyes or face

  • unconsciousness

  • unusual tiredness or weakness

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Rare
  • Feeling that others are watching you or controlling your behavior

  • feeling that others can hear your thoughts

  • feeling, seeing, or hearing things that are not there

  • muscular pain, tenderness, wasting, or weakness

  • severe mood or mental changes

  • unusual behavior

Incidence not known
  • Belching

  • bloated or full feeling

  • drowsiness

  • excess air or gas in the stomach or intestines

  • indigestion

  • not able to concentrate

  • pain or discomfort in the chest, upper stomach, or throat

  • weight loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rifadin side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Rifadin resources


  • Rifadin Side Effects (in more detail)
  • Rifadin Use in Pregnancy & Breastfeeding
  • Drug Images
  • Rifadin Drug Interactions
  • Rifadin Support Group
  • 1 Review for Rifadin - Add your own review/rating


  • Rifadin Concise Consumer Information (Cerner Multum)

  • Rifadin MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rifadin Prescribing Information (FDA)

  • Rifampin Professional Patient Advice (Wolters Kluwer)

  • Rifampin Monograph (AHFS DI)

  • Rifadin IV MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Rifadin with other medications


  • Bartonellosis
  • Endocarditis
  • Haemophilus influenzae Prophylaxis
  • Legionella Pneumonia
  • Leprosy
  • Leprosy, Borderline
  • Leprosy, Tuberculoid
  • Meningitis
  • Meningococcal Meningitis Prophylaxis
  • Nasal Carriage of Staphylococcus aureus
  • Tuberculosis, Active
  • Tuberculosis, Latent
  • Tuberculosis, Prophylaxis

Wednesday, 1 September 2010

Gentamicina + Betametasone Hexal




Gentamicina + Betametasone Hexal may be available in the countries listed below.


Ingredient matches for Gentamicina + Betametasone Hexal



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Gentamicina + Betametasone Hexal in the following countries:


  • Italy

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicina + Betametasone Hexal in the following countries:


  • Italy

International Drug Name Search

Monday, 23 August 2010

Children's Motrin Cold




Ingredient matches for Children's Motrin Cold



Ibuprofen

Ibuprofen is reported as an ingredient of Children's Motrin Cold in the following countries:


  • United States

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Children's Motrin Cold in the following countries:


  • United States

International Drug Name Search

Thursday, 12 August 2010

Testosterone Undecanoate




Testosterone Undecanoate may be available in the countries listed below.


Ingredient matches for Testosterone Undecanoate



Testosterone

Testosterone Undecanoate (BANM, USAN) is known as Testosterone in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 11 August 2010

Kineadorr




Kineadorr may be available in the countries listed below.


Ingredient matches for Kineadorr



Epalrestat

Epalrestat is reported as an ingredient of Kineadorr in the following countries:


  • Japan

International Drug Name Search

Tuesday, 10 August 2010

Celtop




Celtop may be available in the countries listed below.


Ingredient matches for Celtop



Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Celtop in the following countries:


  • Japan

International Drug Name Search

Duphatroxim




Duphatroxim may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Duphatroxim



Sulfadiazine

Sulfadiazine is reported as an ingredient of Duphatroxim in the following countries:


  • Belgium

  • Luxembourg

  • Netherlands

Trimethoprim

Trimethoprim is reported as an ingredient of Duphatroxim in the following countries:


  • Belgium

  • Luxembourg

  • Netherlands

International Drug Name Search

Thursday, 5 August 2010

Aristospan




In the US, Aristospan (triamcinolone systemic) is a member of the drug class glucocorticoids and is used to treat Alopecia, Keloids, Lichen Planus, Lichen Sclerosus, Lichen Simplex Chronicus, Psoriasis and Systemic Lupus Erythematosus.

US matches:

  • Aristospan Suspension

  • Aristospan injection

  • Aristospan

Ingredient matches for Aristospan



Triamcinolone

Triamcinolone hexacetonide (a derivative of Triamcinolone) is reported as an ingredient of Aristospan in the following countries:


  • United States

International Drug Name Search

Monday, 2 August 2010

Flodin




Flodin may be available in the countries listed below.


Ingredient matches for Flodin



Meloxicam

Meloxicam is reported as an ingredient of Flodin in the following countries:


  • Peru

International Drug Name Search

Saturday, 17 July 2010

Alzen Orifarm




Alzen Orifarm may be available in the countries listed below.


Ingredient matches for Alzen Orifarm



Quetiapine

Quetiapine is reported as an ingredient of Alzen Orifarm in the following countries:


  • Denmark

International Drug Name Search

Thursday, 15 July 2010

Alpha-Lipogamma




Alpha-Lipogamma may be available in the countries listed below.


Ingredient matches for Alpha-Lipogamma



Thioctic Acid

Thioctic Acid is reported as an ingredient of Alpha-Lipogamma in the following countries:


  • Germany

Thioctic Acid ethylenediamine (a derivative of Thioctic Acid) is reported as an ingredient of Alpha-Lipogamma in the following countries:


  • Germany

Thioctic Acid meglumine (a derivative of Thioctic Acid) is reported as an ingredient of Alpha-Lipogamma in the following countries:


  • Germany

International Drug Name Search

Wednesday, 14 July 2010

Alcoxidine




Alcoxidine may be available in the countries listed below.


Ingredient matches for Alcoxidine



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Alcoxidine in the following countries:


  • Israel

International Drug Name Search

Saturday, 3 July 2010

Mydral




In the US, Mydral (tropicamide ophthalmic) is a member of the drug class mydriatics and is used to treat Pupillary Dilation and Refraction - Assessment.

US matches:

  • Mydral

  • Mydral Ophthalmic

Ingredient matches for Mydral



Tropicamide

Tropicamide is reported as an ingredient of Mydral in the following countries:


  • United States

International Drug Name Search

Wednesday, 30 June 2010

Detens




Detens may be available in the countries listed below.


Ingredient matches for Detens



Clobazam

Clobazam is reported as an ingredient of Detens in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 25 June 2010

Nevipan




Nevipan may be available in the countries listed below.


Ingredient matches for Nevipan



Nevirapine

Nevirapine is reported as an ingredient of Nevipan in the following countries:


  • Ethiopia

  • Myanmar

International Drug Name Search

Friday, 18 June 2010

Docbudeso




Docbudeso may be available in the countries listed below.


Ingredient matches for Docbudeso



Budesonide

Budesonide is reported as an ingredient of Docbudeso in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Thursday, 17 June 2010

Diastat AcuDial


See also: Generic Diastat


Diastat AcuDial is a brand name of diazepam, approved by the FDA in the following formulation(s):


DIASTAT ACUDIAL (diazepam - gel; rectal)



  • Manufacturer: VALEANT

    Approval date: September 15, 2005

    Strength(s): 10MG/2ML (5MG/ML), 20MG/4ML (5MG/ML) [RLD]

Has a generic version of Diastat AcuDial been approved?


No. There is currently no therapeutically equivalent version of Diastat AcuDial available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diastat AcuDial. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Rectally-administered, epileptic-seizure-inhibiting composition
    Patent 5,462,740
    Issued: October 31, 1995
    Inventor(s): Evenstad; Kenneth L. & O'Neill; Victoria A. & Gorham; Thomas R.
    Assignee(s): Athena Neurosciences, Inc.
    This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.
    Patent expiration dates:

    • September 17, 2013
      ✓ 
      Drug product



See also...

  • Diastat AcuDial Gel Consumer Information (Wolters Kluwer)
  • Diastat AcuDial Consumer Information (Cerner Multum)
  • Diazepam Consumer Information (Drugs.com)
  • Diazepam Consumer Information (Wolters Kluwer)
  • Diazepam Concentrate Consumer Information (Wolters Kluwer)
  • Diazepam Gel Consumer Information (Wolters Kluwer)
  • Diazepam Solution Consumer Information (Wolters Kluwer)
  • Diazepam Tablets Consumer Information (Wolters Kluwer)
  • Diazepam Consumer Information (Cerner Multum)
  • Diazepam rectal Consumer Information (Cerner Multum)
  • Diazepam Advanced Consumer Information (Micromedex)
  • Diazepam Injection Advanced Consumer Information (Micromedex)
  • Diazepam Rectal Advanced Consumer Information (Micromedex)
  • Diazepam AHFS DI Monographs (ASHP)

Mobic




In the US, Mobic (meloxicam systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Fibromyalgia, Inflammatory Conditions, Juvenile Rheumatoid Arthritis, Osteoarthritis, Rheumatoid Arthritis and Tendonitis.

US matches:

  • Mobic

  • Mobic Suspension

UK matches:

  • Mobic Suppositories 15mg
  • Mobic Suppositories 7.5mg
  • Mobic Tablets 15mg
  • Mobic Tablets 7.5mg
  • Mobic 15mg Suppositories (SPC)
  • Mobic 15mg Tablets (SPC)
  • Mobic 7.5mg Suppositories (SPC)
  • Mobic 7.5mg Tablets (SPC)

Ingredient matches for Mobic



Meloxicam

Meloxicam is reported as an ingredient of Mobic in the following countries:


  • Argentina

  • Australia

  • Bahrain

  • Belgium

  • Colombia

  • Cyprus

  • Egypt

  • Finland

  • France

  • Guyana

  • Hong Kong

  • Iraq

  • Ireland

  • Italy

  • Japan

  • Jordan

  • Kenya

  • Kuwait

  • Lebanon

  • Libya

  • Luxembourg

  • Malaysia

  • Malta

  • New Zealand

  • Norway

  • Oman

  • Peru

  • Qatar

  • Saudi Arabia

  • Singapore

  • South Africa

  • Sudan

  • Taiwan

  • Thailand

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 6 June 2010

Dolgic LQ Elixir


Pronunciation: ah-seet-ah-MIN-oh-fen/byoo-TAL-bi-tal/kaf-EEN
Generic Name: Acetaminophen/Butalbital/Caffeine
Brand Name: Examples include Alagesic LQ and Dolgic LQ

Dolgic LQ Elixir contains acetaminophen. Severe and sometimes fatal liver problems, including the need for liver transplant, have been reported with the use of acetaminophen. Most cases of these liver problems occurred in patients taking excessive doses of acetaminophen (more than 4,000 mg per day). Also, patients who developed these liver problems were often using more than 1 medicine that contained acetaminophen. Discuss any questions or concerns with your doctor.





Dolgic LQ Elixir is used for:

Relieving tension headaches. It may also be used for other conditions as determined by your doctor.


How these medicines work is not completely understood. Acetaminophen works in the brain to relieve pain. Caffeine may work by constricting blood vessels that may cause headaches. Butalbital has a depressant effect that reduces anxiety and causes relaxation.


Do NOT use Dolgic LQ Elixir if:


  • you are allergic to any ingredient in Dolgic LQ Elixir

  • you have the blood disease porphyria

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dolgic LQ Elixir:


Some medical conditions may interact with Dolgic LQ Elixir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have liver problems, severe kidney problems, severe heart disease, a lung or respiratory tract disease, or difficulty sleeping

  • if you have a history of substance abuse or dependence, anxiety, depression, or suicidal thoughts or behaviors

Some MEDICINES MAY INTERACT with Dolgic LQ Elixir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Benzodiazepines (eg, chlordiazepoxide), monoamine oxidase inhibitors (MAOIs) (eg, phenelzine), narcotic analgesics (eg, morphine), sleeping medicines (eg, temazepam), or sodium oxybate (GHB) because they may increase the risk of Dolgic LQ Elixir's side effects

  • Anticoagulants (eg, warfarin) or isoniazid because the risk of side effects, including bleeding and liver problems, may be increased

  • Beta-blockers (eg, atenolol), clozapine, corticosteroids (eg, prednisone), doxycycline, estrogens (eg, estradiol, oral contraceptives), metronidazole, quinidine, quinolone antibiotics (eg, ciprofloxacin), or theophylline, because their effectiveness may be decreased by Dolgic LQ Elixir

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dolgic LQ Elixir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dolgic LQ Elixir:


Use Dolgic LQ Elixir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Dolgic LQ Elixir by mouth with or without food.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Dolgic LQ Elixir and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is almost time for your next dose, do not double the dose to catch up, unless advised to do so by your doctor. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dolgic LQ Elixir.



Important safety information:


  • Dolgic LQ Elixir may cause drowsiness. This effect may be worse if you take it with alcohol or certain medicines. Use Dolgic LQ Elixir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Dolgic LQ Elixir; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Pain medications work best if they are used as the first signs of pain (or migraine) occur. If you wait until the pain has significantly worsened, the pain medicine may not work as well.

  • Dolgic LQ Elixir has acetaminophen in it. Before you start any new medicine, check the label to see if it has acetaminophen in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Dolgic LQ Elixir may harm your liver. Your risk may be greater if you drink alcohol while you are using Dolgic LQ Elixir. Talk to your doctor before you take Dolgic LQ Elixir or other pain relievers/fever reducers if you drink more than 3 drinks with alcohol per day.

  • Tell your doctor or dentist that you take Dolgic LQ Elixir before you receive any medical or dental care, emergency care, or surgery.

  • Hormonal birth control (eg, birth control pills) may not work as well while you are using Dolgic LQ Elixir. To prevent pregnancy, use an extra form of birth control (eg, condoms).

  • Lab tests, including liver and kidney function, may be performed while you use Dolgic LQ Elixir. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Dolgic LQ Elixir with caution in the ELDERLY; they may be more sensitive to its effects.

  • Dolgic LQ Elixir should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dolgic LQ Elixir while you are pregnant. Dolgic LQ Elixir is found in breast milk. Do not breast-feed while taking Dolgic LQ Elixir.

When used for long periods of time or at high doses, Dolgic LQ Elixir may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Dolgic LQ Elixir stops working well. Do not take more than prescribed.


Some people who use Dolgic LQ Elixir for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. If you stop taking Dolgic LQ Elixir suddenly, you may have WITHDRAWAL symptoms. These may include anxiety, muscle twitching, trembling hands and fingers, weakness, dizziness, hallucinations, nausea, vomiting, sleeplessness, lightheadedness, or seizures.



Possible side effects of Dolgic LQ Elixir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; intoxicated feeling; lightheadedness; nausea.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; seizures; severe drowsiness; shortness of breath; slurred speech; stomach pain; weakness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dolgic LQ side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include cold or clammy skin; confusion; dark urine; excessive sweating; extremely fast heartbeat; fatigue; lack of alertness; lightheadedness; loss of consciousness; nausea; sleeplessness; slow or shallow breathing; stomach pain; tremor; unusual drowsiness or dizziness; vomiting.


Proper storage of Dolgic LQ Elixir:

Store Dolgic LQ Elixir at room temperature between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dolgic LQ Elixir out of the reach of children and away from pets.


General information:


  • If you have any questions about Dolgic LQ Elixir, please talk with your doctor, pharmacist, or other health care provider.

  • Dolgic LQ Elixir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dolgic LQ Elixir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dolgic LQ resources


  • Dolgic LQ Side Effects (in more detail)
  • Dolgic LQ Use in Pregnancy & Breastfeeding
  • Dolgic LQ Drug Interactions
  • Dolgic LQ Support Group
  • 0 Reviews for Dolgic LQ - Add your own review/rating


Compare Dolgic LQ with other medications


  • Headache

Griseofort




Griseofort may be available in the countries listed below.


Ingredient matches for Griseofort



Griseofulvin

Griseofulvin is reported as an ingredient of Griseofort in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 3 June 2010

Metotressato Teva




Metotressato Teva may be available in the countries listed below.


Ingredient matches for Metotressato Teva



Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Metotressato Teva in the following countries:


  • Italy

International Drug Name Search

Saturday, 22 May 2010

Forenium




Forenium may be available in the countries listed below.


Ingredient matches for Forenium



Isoflurane

Isoflurane is reported as an ingredient of Forenium in the following countries:


  • Greece

International Drug Name Search

Thursday, 20 May 2010

Narbel




Narbel may be available in the countries listed below.


Ingredient matches for Narbel



Tetryzoline

Tetryzoline is reported as an ingredient of Narbel in the following countries:


  • Japan

International Drug Name Search

Tuesday, 18 May 2010

Mianserin HCl ratiopharm




Mianserin HCl ratiopharm may be available in the countries listed below.


Ingredient matches for Mianserin HCl ratiopharm



Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Mianserin HCl ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 16 May 2010

Phénylbutazone




Phénylbutazone may be available in the countries listed below.


Ingredient matches for Phénylbutazone



Phenylbutazone

Phénylbutazone (DCF) is known as Phenylbutazone in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 15 May 2010

Bactotril




Bactotril may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bactotril



Sulfadimethoxine

Sulfadimethoxine sodium (a derivative of Sulfadimethoxine) is reported as an ingredient of Bactotril in the following countries:


  • France

Trimethoprim

Trimethoprim is reported as an ingredient of Bactotril in the following countries:


  • France

International Drug Name Search

Thursday, 13 May 2010

Potencort




Potencort may be available in the countries listed below.


Ingredient matches for Potencort



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Potencort in the following countries:


  • Oman

International Drug Name Search

Wednesday, 12 May 2010

Bain extra-doux Widmer




Bain extra-doux Widmer may be available in the countries listed below.


Ingredient matches for Bain extra-doux Widmer



Guaiazulene

Guaiazulene is reported as an ingredient of Bain extra-doux Widmer in the following countries:


  • Switzerland

Ichthammol

Ichthammol decolorized (a derivative of Ichthammol) is reported as an ingredient of Bain extra-doux Widmer in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 6 May 2010

Ketifen




Ketifen may be available in the countries listed below.


Ingredient matches for Ketifen



Ketotifen

Ketotifen is reported as an ingredient of Ketifen in the following countries:


  • Dominican Republic

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Ketifen in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 3 May 2010

Kefdrin




Kefdrin may be available in the countries listed below.


Ingredient matches for Kefdrin



Cefradine

Cefradine is reported as an ingredient of Kefdrin in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 10 April 2010

Prazene




Prazene may be available in the countries listed below.


Ingredient matches for Prazene



Prazepam

Prazepam is reported as an ingredient of Prazene in the following countries:


  • Italy

International Drug Name Search

Friday, 9 April 2010

Neofollin




Neofollin may be available in the countries listed below.


Ingredient matches for Neofollin



Estradiol

Estradiol 17Ăź-valerate (a derivative of Estradiol) is reported as an ingredient of Neofollin in the following countries:


  • Czech Republic

  • Slovakia

International Drug Name Search

Nufaclapide




Nufaclapide may be available in the countries listed below.


Ingredient matches for Nufaclapide



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Nufaclapide in the following countries:


  • Indonesia

International Drug Name Search

Friday, 2 April 2010

Diasec




Diasec may be available in the countries listed below.


Ingredient matches for Diasec



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Diasec in the following countries:


  • Brazil

  • Indonesia

International Drug Name Search

Thursday, 1 April 2010

Amofar




Amofar may be available in the countries listed below.


Ingredient matches for Amofar



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amofar in the following countries:


  • Venezuela

International Drug Name Search

Wednesday, 31 March 2010

Bacsul Forte




Bacsul Forte may be available in the countries listed below.


Ingredient matches for Bacsul Forte



Guaifenesin

Guaifenesin is reported as an ingredient of Bacsul Forte in the following countries:


  • Peru

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Bacsul Forte in the following countries:


  • Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Bacsul Forte in the following countries:


  • Peru

International Drug Name Search

Saturday, 27 March 2010

Fentora


Fentora is a brand name of fentanyl, approved by the FDA in the following formulation(s):


FENTORA (fentanyl citrate - tablet; buccal)



  • Manufacturer: CEPHALON

    Approval date: September 25, 2006

    Strength(s): EQ 0.1MG BASE [AB], EQ 0.2MG BASE [AB], EQ 0.4MG BASE [RLD][AB], EQ 0.6MG BASE [AB], EQ 0.8MG BASE [AB]

Has a generic version of Fentora been approved?


A generic version of Fentora has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Fentora and have been approved by the FDA:


fentanyl citrate tablet; buccal



  • Manufacturer: WATSON LABS

    Approval date: January 7, 2011

    Strength(s): EQ 0.1MG BASE [AB], EQ 0.2MG BASE [AB], EQ 0.4MG BASE [AB], EQ 0.6MG BASE [AB], EQ 0.8MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fentora. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Sublingual buccal effervescent
    Patent 6,200,604
    Issued: March 13, 2001
    Inventor(s): Pather; Sathasivan Indiran & Khankari; Rajendra K. & Eichman; Jonathan D. & Robinson; Joseph R. & Hontz; John
    Assignee(s): Cima Labs Inc.
    A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
    Patent expiration dates:

    • March 26, 2019
      ✓ 
      Patent use: MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER




  • Sublingual buccal effervescent
    Patent 6,974,590
    Issued: December 13, 2005
    Inventor(s): Pather; Sathasivan Indiran & Khankari; Rajendra K. & Eichman; Jonathan D. & Robinson; Joseph R. & Hontz; John
    Assignee(s): Cima Labs Inc.
    A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
    Patent expiration dates:

    • March 26, 2019
      ✓ 
      Patent use: MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER




  • Generally linear effervescent oral fentanyl dosage form and methods of administering
    Patent 7,862,832
    Issued: January 4, 2011
    Inventor(s): Moe; Derek & Agarwal; Vikas & Habib; Walid
    Assignee(s): Cima Labs, Inc.
    Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
    Patent expiration dates:

    • June 15, 2028
      ✓ 
      Drug product




  • Effervescent oral opiate dosage forms and methods of administering opiates
    Patent 7,862,833
    Issued: January 4, 2011
    Inventor(s): Moe; Derek
    Assignee(s): Cima Labs, Inc.
    Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended for oral administration across the oral mucosa.
    Patent expiration dates:

    • June 15, 2028
      ✓ 
      Drug product




  • Generally linear effervescent oral fentanyl dosage form and methods of administering
    Patent 8,092,832
    Issued: January 10, 2012
    Inventor(s): Moe; Derek & Agarwal; Vikas & Habib; Walib
    Assignee(s): Cephalon, Inc.
    Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
    Patent expiration dates:

    • December 30, 2024
      ✓ 
      Drug product



See also...

  • Fentora Consumer Information (Drugs.com)
  • Fentora Consumer Information (Wolters Kluwer)
  • Fentora buccal Consumer Information (Cerner Multum)
  • Fentora Advanced Consumer Information (Micromedex)
  • Fentanyl Consumer Information (Drugs.com)
  • Fentanyl Consumer Information (Wolters Kluwer)
  • Fentanyl Lozenge Consumer Information (Wolters Kluwer)
  • Fentanyl Patch Consumer Information (Wolters Kluwer)
  • Fentanyl Soluble Film Consumer Information (Wolters Kluwer)
  • Fentanyl Spray Consumer Information (Wolters Kluwer)
  • Fentanyl Tablet Consumer Information (Wolters Kluwer)
  • Fentanyl buccal Consumer Information (Cerner Multum)
  • Fentanyl citrate oral transmucosal Consumer Information (Cerner Multum)
  • Fentanyl nasal Consumer Information (Cerner Multum)
  • Fentanyl sublingual Consumer Information (Cerner Multum)
  • Fentanyl transdermal device Consumer Information (Cerner Multum)
  • Fentanyl transdermal skin patch Consumer Information (Cerner Multum)
  • Fentanyl Buccal mucosa, Oromucosal Advanced Consumer Information (Micromedex)
  • Fentanyl Nasal Advanced Consumer Information (Micromedex)
  • Fentanyl Transdermal Advanced Consumer Information (Micromedex)
  • Fentanyl Citrate AHFS DI Monographs (ASHP)